This indicates that free DNA is the most useful diagnostic marker for lung cancer and that the combination of DNA with either PPBP and PADI4 or COX2 could improve diagnostic accuracy, especially of early stage tumors. This evidence concerns the gene PADI4 and lung carcinoma.